The study assessed the cost-effectiveness of consuming 42.5 g of almond from the US healthcare sector perspective. Researchers developed a decision model for CVD primary prevention among adults who consumed 42.5 g of (1.5 oz) almonds per day (almond strategy), as compared with no almond consumption (non-almond strategy) to project 1-year health outcomes and CVD-related costs.
The target population of this study was US adults with increased risk of type 2 diabetes, including overweight or obese, or normal-weight adults with a strong family history of diabetes. The randomized control trial recruited a total of 150 participants with a mean age of 30 years old.
The study observed that increasing almond consumption could be significant for American population, who consume an average of 2.93 g of almonds per day. In conclusion, consuming 42.5 g of almonds per day is a cost-effective approach to prevent cardiovascular disease in the short term and potentially in the long term.
The target population of this study was US adults with increased risk of type 2 diabetes, including overweight or obese, or normal-weight adults with a strong family history of diabetes. The randomized control trial recruited a total of 150 participants with a mean age of 30 years old.
The study observed that increasing almond consumption could be significant for American population, who consume an average of 2.93 g of almonds per day. In conclusion, consuming 42.5 g of almonds per day is a cost-effective approach to prevent cardiovascular disease in the short term and potentially in the long term.
This study was funded by the Almond Board of California.
Wang, J., Lee Bravatti, M. A., Johnson, E. J., & Raman, G. (2020). Daily almond consumption in cardiovascular disease prevention via LDL-C change in the U.S. population: a cost-effectiveness analysis. BMC public health, 20(1), 558. https://doi.org/10.1186/s12889-020-08642-4